HGC-245

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameHGC-245
Drug Alias NameHGC-245
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRho-associated protein kinase 2 inhibitors
TargetsRho-associated protein kinase 2
Therapy Area/IndicationsGlaucoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHitgen Inc
China Registration ClassN/A

Develop Information

Active CompaniesHitgen Inc
Inactive CompaniesN/A
Active IndicationsGlaucoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A